基于运动的心力衰竭心脏康复:对心声学参数和功能能力的影响:一项随机临床试验
Zahra Mahmoodi1, Arsalan Salari1, Zahra Ahmadnia1
1Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
同时进行运动训练显著改善了心力衰竭患者的功能能力和心声回声测量,减少排气分数 (HFrEF). 这种心脏康复方法可以提高老年人的心脏功能和运动能力.
科学领域:
- 心脏病学 心脏病学
- 运动生理学 运动生理学
- 康复医学 康复医学 康复医学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭带来了复杂的生理挑战.
- 有效的以运动为基础的康复策略对于管理HFrEF至关重要.
- 同时运动训练结合了有氧和阻力元素,以获得全面的益处.
研究的目的:
- 评估8周并发运动训练计划对HFrEF患者的影响.
- 为了比较干预和对照组之间的心声回声学参数和功能能力的变化.
- 评估基于运动的心脏康复在改善HFrEF结果方面的有效性.
主要方法:
- 一项随机对照试验,涉及76名HFrEF患者 (平均年龄68.2岁).
- 参与者被分配到干预组 (同时运动+呼吸练习) 或对照组.
- 在干预前和后测量了心声学参数 (射出分数,心室尺寸) 和6分钟步行测试.
主要成果:
- 干预组在6分钟的步行测试距离 (273m vs 204.2m) 中显著改善.
- 在干预组中,喷射分数显著增加 (37.23%对28.28%).
- 在干预组中,左心室尺寸 (终端-透气和终端-收缩) 显著下降.
结论:
- 同时进行运动训练是改善HFrEF患者功能能力的有效干预措施.
- 这种运动方案对关键的心声回声测量有积极的影响,包括喷射率和心室大小.
- 这些发现支持对HFrEF的老年人进行基于运动的心脏康复的更广泛的临床实施.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
相关概念视频
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
